HEADER RNA BINDING PROTEIN/INHIBITOR 28-APR-20 7BZJ
TITLE THE DISCOVERY OF BENZHYDROL-OXABOROLE HYBRID DERIVATIVES AS LEUCYL-
TITLE 2 TRNA SYNTHETASE INHIBITORS
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: LEUCINE--TRNA LIGASE;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: LEUCYL-TRNA SYNTHETASE,LEURS;
COMPND 5 EC: 6.1.1.4;
COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOCOCCUS PNEUMONIAE (STRAIN ATCC 700669 /
SOURCE 3 SPAIN 23F-1);
SOURCE 4 ORGANISM_TAXID: 561276;
SOURCE 5 STRAIN: ATCC 700669 / SPAIN 23F-1;
SOURCE 6 GENE: LEUS, SPN23F02440;
SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS LEUCYL-TRNA SYNTHETASE, PNEUMONIA, RNA BINDING PROTEIN-INHIBITOR
KEYWDS 2 COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR R.J.LIU,H.LI,E.D.WANG,H.ZHOU
REVDAT 3 29-NOV-23 7BZJ 1 REMARK
REVDAT 2 03-FEB-21 7BZJ 1 JRNL
REVDAT 1 09-DEC-20 7BZJ 0
JRNL AUTH G.HAO,H.LI,F.YANG,D.DONG,Z.LI,Y.DING,W.PAN,E.WANG,R.LIU,
JRNL AUTH 2 H.ZHOU
JRNL TITL DISCOVERY OF BENZHYDROL-OXABOROLE DERIVATIVES AS
JRNL TITL 2 STREPTOCOCCUS PNEUMONIAE LEUCYL-TRNA SYNTHETASE INHIBITORS.
JRNL REF BIOORG.MED.CHEM. V. 29 15871 2021
JRNL REFN ESSN 1464-3391
JRNL PMID 33221064
JRNL DOI 10.1016/J.BMC.2020.115871
REMARK 2
REMARK 2 RESOLUTION. 2.00 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : PHENIX V1.18
REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK 3
REMARK 3 REFINEMENT TARGET : ML
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.40
REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8
REMARK 3 NUMBER OF REFLECTIONS : 21233
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 R VALUE (WORKING + TEST SET) : 0.189
REMARK 3 R VALUE (WORKING SET) : 0.188
REMARK 3 FREE R VALUE : 0.217
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.140
REMARK 3 FREE R VALUE TEST SET COUNT : 1092
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE
REMARK 3 1 31.4000 - 4.0000 0.99 2716 133 0.1768 0.1817
REMARK 3 2 4.0000 - 3.1800 1.00 2569 133 0.1628 0.1959
REMARK 3 3 3.1800 - 2.7800 1.00 2523 137 0.1992 0.2254
REMARK 3 4 2.7800 - 2.5200 1.00 2478 143 0.1988 0.2067
REMARK 3 5 2.5200 - 2.3400 1.00 2497 128 0.1996 0.2956
REMARK 3 6 2.3400 - 2.2000 1.00 2436 165 0.2036 0.2419
REMARK 3 7 2.2000 - 2.0900 1.00 2460 116 0.2137 0.2578
REMARK 3 8 2.0900 - 2.0000 1.00 2462 137 0.2301 0.2750
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL
REMARK 3 SOLVENT RADIUS : 1.11
REMARK 3 SHRINKAGE RADIUS : 0.90
REMARK 3 K_SOL : NULL
REMARK 3 B_SOL : NULL
REMARK 3
REMARK 3 ERROR ESTIMATES.
REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.230
REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.000
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.22
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 TWINNING INFORMATION.
REMARK 3 FRACTION: NULL
REMARK 3 OPERATOR: NULL
REMARK 3
REMARK 3 DEVIATIONS FROM IDEAL VALUES.
REMARK 3 RMSD COUNT
REMARK 3 BOND : NULL NULL
REMARK 3 ANGLE : NULL NULL
REMARK 3 CHIRALITY : NULL NULL
REMARK 3 PLANARITY : NULL NULL
REMARK 3 DIHEDRAL : NULL NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 NCS DETAILS
REMARK 3 NUMBER OF NCS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 7BZJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 07-MAY-20.
REMARK 100 THE DEPOSITION ID IS D_1300016784.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 18-MAR-17
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : NULL
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : SSRF
REMARK 200 BEAMLINE : BL19U1
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.9785
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : PIXEL
REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21319
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0
REMARK 200 DATA REDUNDANCY : 34.20
REMARK 200 R MERGE (I) : 0.19600
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 4.3000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.03
REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9
REMARK 200 DATA REDUNDANCY IN SHELL : 21.80
REMARK 200 R MERGE FOR SHELL (I) : 1.46200
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: MOLREP
REMARK 200 STARTING MODEL: 4K48
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 65.26
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.54
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M BIS-TRIS (PH5.5), 2.1M AMMONIUM
REMARK 280 SULFATE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 289K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -Y,X-Y,Z+1/3
REMARK 290 3555 -X+Y,-X,Z+2/3
REMARK 290 4555 -X,-Y,Z+1/2
REMARK 290 5555 Y,-X+Y,Z+5/6
REMARK 290 6555 X-Y,X,Z+1/6
REMARK 290 7555 Y,X,-Z+1/3
REMARK 290 8555 X-Y,-Y,-Z
REMARK 290 9555 -X,-X+Y,-Z+2/3
REMARK 290 10555 -Y,-X,-Z+5/6
REMARK 290 11555 -X+Y,Y,-Z+1/2
REMARK 290 12555 X,X-Y,-Z+1/6
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.17600
REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 90.35200
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 67.76400
REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 112.94000
REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 22.58800
REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 45.17600
REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 90.35200
REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 112.94000
REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 67.76400
REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 22.58800
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 375
REMARK 375 SPECIAL POSITION
REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS
REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL
REMARK 375 POSITIONS.
REMARK 375
REMARK 375 ATOM RES CSSEQI
REMARK 375 HOH A 755 LIES ON A SPECIAL POSITION.
REMARK 375 HOH A 759 LIES ON A SPECIAL POSITION.
REMARK 375 HOH A 771 LIES ON A SPECIAL POSITION.
REMARK 375 HOH A 784 LIES ON A SPECIAL POSITION.
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 227
REMARK 465 LEU A 411
REMARK 465 GLU A 412
REMARK 465 HIS A 413
REMARK 465 HIS A 414
REMARK 465 HIS A 415
REMARK 465 HIS A 416
REMARK 465 HIS A 417
REMARK 465 HIS A 418
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 O HOH A 601 O HOH A 732 1.93
REMARK 500 O ALA A 371 O HOH A 601 2.07
REMARK 500 OD1 ASP A 282 O HOH A 602 2.19
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS
REMARK 500
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375
REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.
REMARK 500
REMARK 500 DISTANCE CUTOFF:
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE
REMARK 500 NZ LYS A 403 O HOH A 601 6555 2.18
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASP A 382 -120.22 50.90
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue FGX A 501
DBREF 7BZJ A 228 410 UNP B8ZKS5 SYL_STRPJ 228 410
SEQADV 7BZJ MET A 227 UNP B8ZKS5 INITIATING METHIONINE
SEQADV 7BZJ SER A 399 UNP B8ZKS5 CYS 399 ENGINEERED MUTATION
SEQADV 7BZJ LEU A 411 UNP B8ZKS5 EXPRESSION TAG
SEQADV 7BZJ GLU A 412 UNP B8ZKS5 EXPRESSION TAG
SEQADV 7BZJ HIS A 413 UNP B8ZKS5 EXPRESSION TAG
SEQADV 7BZJ HIS A 414 UNP B8ZKS5 EXPRESSION TAG
SEQADV 7BZJ HIS A 415 UNP B8ZKS5 EXPRESSION TAG
SEQADV 7BZJ HIS A 416 UNP B8ZKS5 EXPRESSION TAG
SEQADV 7BZJ HIS A 417 UNP B8ZKS5 EXPRESSION TAG
SEQADV 7BZJ HIS A 418 UNP B8ZKS5 EXPRESSION TAG
SEQRES 1 A 192 MET THR GLY ALA ASN VAL THR PHE LYS VAL LYS GLY THR
SEQRES 2 A 192 ASP LYS GLU PHE THR VAL PHE THR THR ARG PRO ASP THR
SEQRES 3 A 192 LEU PHE GLY ALA THR PHE THR VAL LEU ALA PRO GLU HIS
SEQRES 4 A 192 GLU LEU VAL ASP ALA ILE THR SER SER GLU GLN ALA GLU
SEQRES 5 A 192 ALA VAL ALA ASP TYR LYS HIS GLN ALA SER LEU LYS SER
SEQRES 6 A 192 ASP LEU VAL ARG THR ASP LEU ALA LYS GLU LYS THR GLY
SEQRES 7 A 192 VAL TRP THR GLY ALA TYR ALA ILE ASN PRO VAL ASN GLY
SEQRES 8 A 192 LYS GLU MET PRO ILE TRP ILE ALA ASP TYR VAL LEU ALA
SEQRES 9 A 192 SER TYR GLY THR GLY ALA VAL MET ALA VAL PRO ALA HIS
SEQRES 10 A 192 ASP GLN ARG ASP TRP GLU PHE ALA LYS GLN PHE ASP LEU
SEQRES 11 A 192 PRO ILE VAL GLU VAL LEU GLU GLY GLY ASN VAL GLU GLU
SEQRES 12 A 192 ALA ALA TYR THR GLU ASP GLY LEU HIS VAL ASN SER ASP
SEQRES 13 A 192 PHE LEU ASP GLY LEU ASN LYS GLU ASP ALA ILE ALA LYS
SEQRES 14 A 192 ILE VAL ALA SER LEU GLU GLU LYS GLY CYS GLY GLN GLU
SEQRES 15 A 192 LYS VAL LEU GLU HIS HIS HIS HIS HIS HIS
HET FGX A 501 76
HETNAM FGX [(1~{R},5~{R},6~{S},8~{R})-8-(6-AMINOPURIN-9-YL)-4'-
HETNAM 2 FGX [(~{R})-OXIDANYL-[4-(2-OXIDANYLIDENEPROPYLSULFANYL)
HETNAM 3 FGX PHENYL]METHYL]SPIRO[2,4,7-TRIOXA-3-
HETNAM 4 FGX BORANUIDABICYCLO[3.3.0]OCTANE-3,7'-7-
HETNAM 5 FGX BORANUIDABICYCLO[4.3.0]NONA-1(6),2,4-TRIENE]-6-
HETNAM 6 FGX YL]METHOXY-TRIS(OXIDANYL)PHOSPHANIUM
FORMUL 2 FGX C28 H31 B N5 O9 P S
FORMUL 3 HOH *190(H2 O)
HELIX 1 AA1 ARG A 249 ALA A 256 5 8
HELIX 2 AA2 LEU A 267 THR A 272 1 6
HELIX 3 AA3 GLN A 276 LEU A 289 1 14
HELIX 4 AA4 SER A 291 THR A 296 1 6
HELIX 5 AA5 ASP A 344 ASP A 355 1 12
HELIX 6 AA6 SER A 381 ASP A 385 5 5
HELIX 7 AA7 ASN A 388 GLY A 404 1 17
SHEET 1 AA1 6 GLU A 242 THR A 247 0
SHEET 2 AA1 6 GLY A 229 VAL A 236 -1 N PHE A 234 O PHE A 243
SHEET 3 AA1 6 VAL A 305 ILE A 312 -1 O ILE A 312 N LYS A 235
SHEET 4 AA1 6 GLU A 319 ILE A 324 -1 O MET A 320 N ALA A 311
SHEET 5 AA1 6 PHE A 258 LEU A 261 1 N LEU A 261 O TRP A 323
SHEET 6 AA1 6 ALA A 336 ALA A 339 -1 O ALA A 339 N PHE A 258
SHEET 1 AA2 3 GLU A 242 THR A 247 0
SHEET 2 AA2 3 GLY A 229 VAL A 236 -1 N PHE A 234 O PHE A 243
SHEET 3 AA2 3 GLY A 406 LYS A 409 -1 O GLN A 407 N ASN A 231
SITE 1 AC1 22 PHE A 246 THR A 247 THR A 248 ARG A 249
SITE 2 AC1 22 TYR A 327 VAL A 328 LEU A 329 TYR A 332
SITE 3 AC1 22 VAL A 337 MET A 338 HIS A 343 ASP A 344
SITE 4 AC1 22 THR A 373 LYS A 389 HOH A 606 HOH A 617
SITE 5 AC1 22 HOH A 643 HOH A 660 HOH A 686 HOH A 690
SITE 6 AC1 22 HOH A 696 HOH A 701
CRYST1 87.373 87.373 135.528 90.00 90.00 120.00 P 61 2 2 12
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.011445 0.006608 0.000000 0.00000
SCALE2 0.000000 0.013216 0.000000 0.00000
SCALE3 0.000000 0.000000 0.007379 0.00000